AnaptysBio, Inc. (ANAB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
As of 03:48PM EDT. Market open.
| Previous close | 18.87 |
| Open | 18.92 |
| Bid | 20.81 x 200 |
| Ask | 21.02 x 100 |
| Day's range | 18.72 - 21.61 |
| 52-week range | 13.36 - 27.50 |
| Volume | |
| Avg. volume | 327,327 |
| Market cap | 570.959M |
| Beta (5Y monthly) | -0.29 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Why You Shouldn't Bet Against AnaptysBio (ANAB) Stock.
AnaptysBio (ANAB) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
- Simply Wall St.
Industry Analysts Just Made A Stunning Upgrade To Their AnaptysBio, Inc. (NASDAQ:ANAB) Revenue Forecasts
AnaptysBio, Inc. ( NASDAQ:ANAB ) shareholders will have a reason to smile today, with the analysts making substantial...
- Zacks
What Makes AnaptysBio, Inc. (ANAB) a New Buy Stock
AnaptysBio, Inc. (ANAB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
© 2024 Yahoo. All rights reserved.